Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
FlyCap
RigaSeed–Late Stage$1.1M – $4.3M
6 people
Avedon Capital Partners
AmsterdamGrowth–Late Stage
2 people
Fengate Private Equity
TorontoGrowth–Late Stage
10 people
HongShan
Hong KongPre-Seed–Late Stage$100K – $50M
4 people
Indonesia Investment Authority
JakartaGrowth–Late Stage
4 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
4 people
Socium Ventures
AtlantaSeed–Late Stage$3M – $25M
4 people
Navis Capital Partners
Kuala LumpurGrowth–Late Stage
Unfold Ventures
WrocławPre-Seed–Late Stage$110K – $1.1M
6 people
Amzak Health
New YorkSeed–Late Stage
5 people
Treo Ventures, Llc
MinneapolisSeed–Late Stage
5 people
Auxano
GurugramPre-Seed–Late Stage
7 people
HCS Capital
MiamiSeed–Late Stage
7 people
Agate Medical Investments LP
Tel-AvivGrowth–Late Stage
DTA Capital Partners Sdn. Bhd.
Kuala LumpurSeed–Late Stage$1M
6 people
SIDBI Venture Capital
MumbaiSeed–Late Stage
6 people
TELUS Ventures
VancouverSeed–Late Stage$365K – $36.5M
6 people
Topmark Partners
TampaSeed–Late Stage$2M – $5M
5 people
Fundamental Ventures
LakewayPre-Seed–Late Stage
1 person
Iconica Partners
Silicon ValleySeed–Late Stage
4 people
AddVentures by SCG
BangkokSeed–Late Stage$1.5M – $66M
6 people
Fletcher Spaght, Inc.
BostonLate Stage
9 people
NuVentures
New JerseySeed–Late Stage
Vanterra Ventures
New YorkSeed–Late Stage$500K – $10M
6 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.












































